Page last updated: 2024-08-23

selegiline and Fatigue Syndrome, Chronic

selegiline has been researched along with Fatigue Syndrome, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergen, M; Cheu, J; Dahl, K; Denny, T; Hill, N; Korn, L; Natelson, BH1

Trials

1 trial(s) available for selegiline and Fatigue Syndrome, Chronic

ArticleYear
Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome.
    Neuropsychobiology, 1998, Volume: 37, Issue:3

    Topics: Activities of Daily Living; Affect; Drug Administration Schedule; Fatigue Syndrome, Chronic; Humans; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Selegiline

1998